Biotechnologies Assets SA (BST.MC)

EUR 0.3

(2.54%)

Net Income Summary of Biotechnologies Assets SA

  • Biotechnologies Assets SA's latest annual net income in 2023 was 1.57 Million EUR , up 180.98% from previous year.
  • Biotechnologies Assets SA's latest quarterly net income in 2023 FY was 1.57 Million EUR , up 180.98% from previous quarter.
  • Biotechnologies Assets SA reported an annual net income of -1.94 Million EUR in 2022, up 35.5% from previous year.
  • Biotechnologies Assets SA reported an annual net income of -3.01 Million EUR in 2021, up 64.99% from previous year.
  • Biotechnologies Assets SA reported a quarterly net income of 1.47 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Biotechnologies Assets SA reported a quarterly net income of -689.75 Thousand EUR for 2023 Q3, down -146.71% from previous quarter.

Annual Net Income Chart of Biotechnologies Assets SA (2023 - 2010)

Historical Annual Net Income of Biotechnologies Assets SA (2023 - 2010)

Year Net Income Net Income Growth
2023 1.57 Million EUR 180.98%
2022 -1.94 Million EUR 35.5%
2021 -3.01 Million EUR 64.99%
2020 -8.6 Million EUR 14.64%
2019 -10.08 Million EUR 39.61%
2018 -16.69 Million EUR -22647.97%
2017 -73.39 Thousand EUR 93.54%
2016 -1.13 Million EUR -489.72%
2015 -192.6 Thousand EUR -116.14%
2014 1.19 Million EUR 152.28%
2013 473.05 Thousand EUR 238.29%
2012 -342.08 Thousand EUR -211.01%
2011 308.14 Thousand EUR -44.31%
2010 553.35 Thousand EUR 0.0%

Peer Net Income Comparison of Biotechnologies Assets SA

Name Net Income Net Income Difference
Atrys Health, S.A. -45.59 Million EUR 103.452%
Pharma Mar, S.A. 1.13 Million EUR -38.414%
Laboratorios Farmaceuticos Rovi, S.A. 170.33 Million EUR 99.076%